Plus therapeutics reports positive interim updates from two respect™ clinical trials at snmmi annual meeting

Respect-gbm phase 1 recurrent glioblastoma trial demonstrates safety and overall survival correlation with absorbed radiation dose

pstv Ratings Summary

pstv Quant Ranking